Conditions: Non Small Cell Lung Cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 256
Healthy volunteers: no

Brief summary:
The purpose of this study is to compare the efficacy and safety of two different chemotherapy types in the first line treatment of advanced Non-Small Cell Lung Cancer (NSCLC).

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Pemetrexed intervention 2: Gemcitabine intervention 3: Cisplatin
Intervention descriptions: intervention 1: 500 milligrams/square meter (mg/m²) administered intravenously on Day 1 of each 21-day cycle, for 6 cycles intervention 2: 1250 mg/m² administered intravenously on Day 1 and Day 8 of each 21-day cycle, for 6 cycles intervention 3: 75 mg/m² administered intravenously on day 1 of each 21 day cycle, for 6 cycles

Protocol document: